help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boden, G.
Right arrow Articles by Badosa, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boden, G.
Right arrow Articles by Badosa, F.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 657-663, Copyright © 1994 by Endocrine Society


ARTICLES

Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation

G Boden, X Chen, J Ruiz, M Heifets, M Morris and F Badosa
Division of Endocrinology/Metabolism, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

Patients with insulin-dependent diabetes who receive pancreas/kidney transplants lose their need for insulin injections, but they become hyperinsulinemic and insulin resistant, and sometimes develop noninsulin-dependent diabetes mellitus. The reason for the insulin resistance is not well understood. Specifically, it is not known whether they become resistant to the action of insulin on lipid metabolism. Euglycemic-hyperinsulinemic clamps were performed in six pancreas/kidney (P/K) recipients, six kidney (K) recipients (to control for immunosuppressive therapy), and eight healthy controls. Measured were leg blood flow (by plethysmography), rates of lipolysis (with [2H5] glycerol), fatty acid oxidation (by indirect calorimetry), fatty acid reesterification (with [2H5]glycerol and [1-13C]palmitate), monocyte membrane insulin binding (with [125I]Tyr-A14 insulin), and insulin receptor mass (by RIA). Fasting plasma insulin concentrations were 2 times higher in P/K and K recipients (108 pmol/L) than in controls (54 pmol/L). Insulin receptor mass in solubilized monocyte membranes from P/K and K recipients was reduced by 61% and 63%, respectively, whereas insulin binding was reduced by 73% and 70%, respectively. P/K and K recipients were resistant to the inhibitory action of insulin on lipolysis (P/K vs. controls, P < 0.01; K vs. controls, P < 0.02) and on fatty acid reesterification (P/K vs. controls, P < 0.02; K vs. controls, P < 0.03). P/K recipients appeared to be more resistant than K recipients, but the differences between the two groups were not statistically significant. We conclude that P/K recipients were hyperinsulinemic, had down-regulated the number of their monocyte insulin receptors, and were resistant to the antilipolytic action of insulin.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Tiwari, N. Sharma, P. S. Gill, P. Igarashi, C. R. Kahn, J. B. Wade, and C. M. A. Ecelbarger
Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor
PNAS, April 29, 2008; 105(17): 6469 - 6474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Tiwari, S. Riazi, and C. A. Ecelbarger
Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F974 - F984.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Tiwari, V. K.M. Halagappa, S. Riazi, X. Hu, and C. A. Ecelbarger
Reduced Expression of Insulin Receptors in the Kidneys of Insulin-Resistant Rats
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2661 - 2671.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Bouzakri, H. K.R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J. R. Zierath
IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients
Diabetes, March 1, 2006; 55(3): 785 - 791.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Perseghin, A. Caumo, L. P. Sereni, A. Battezzati, and L. Luzi
Fasting Blood Sample-Based Assessment of Insulin Sensitivity in Kidney-Pancreas-Transplanted Patients
Diabetes Care, December 1, 2002; 25(12): 2207 - 2211.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Carpentier, B. W. Patterson, K. D. Uffelman, A. Giacca, M. Vranic, M. S. Cattral, and G. F. Lewis
The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism
Diabetes, June 1, 2001; 50(6): 1402 - 1413.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Christiansen, A. Tibell, Aa. Volund, J. J. Holst, K. Rasmussen, L. Schaffer, and S. Madsbad
Metabolism of Oral Glucose in Pancreas Transplant Recipients with Normal and Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2299 - 2307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society